1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
601312960154701AC85256C63005B8A83
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/portfolio-development-management-measurement?opendocument
18
19opendocument
2044.222.134.250
21
22
23
24/bestp/domrep.nsf
25DB




» Products & Services » » New Product Development » Early stage commercialization

Portfolio Development, Management & Measurement

DB Image

ID: 4317


Features:

Metrics, Graphics


Words: 7,721


Published: Pre-2019


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Leading companies invest considerable staff, time, resources and share of mind in the area of portfolio development, management and measurement. This 27-page document discusses best practices for continuously prioritizing projects and allocating resources to ensure growth in a portfolio's commercial value. This document highlights best practices in supporting business strategy through an integrated system of portfolio management. Also discussed are prioritization, decision analysis, winning broad support for tough choices, tracking project performance, and portfolio monitoring and measuring.

Industries Profiled:
Biotech; Health Care; Pharmaceutical; Diagnostic; Manufacturing; Consumer Products; Medical Device; Automobile


Companies Profiled:
Allergan; Abbott; Bayer; Bristol-Myers Squibb; Boehringer-Ingelheim; Eli Lilly and Company; GlaxoSmithKline; General Motors; Johnson & Johnson; Novartis; Pfizer

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.